Testing Rates Seem to Be Low for Psychiatric Drug Metabolism


As previously reported, psychiatric drugs are among the most likely to be involved genetically-mediated drug toxicity, due to mutations in various metabolizing cytochrome p450 genes. We conducted an informal survey on a LinkedIn group for psychiatrists, asking them how often they genotyped their patients prior to prescription of drugs with CYP companion diagnostic indications in the labels.

Always 0
Sometimes 3
Never 10

Survey Link

This “study” is of course fraught with caveats as to its reliability, but is interesting nonetheless.


Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access